Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc Health Is Sinking Today

By Eric Volkman – Sep 2, 2020 at 2:49PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A bullish analyst upgrade is met with skepticism by investors.

What happened

Teladoc Health (TDOC -3.40%), a coronavirus stock if ever there was one, was trading slightly down in mid-afternoon action. Curiously, this was despite a significant analyst recommendation upgrade and price target increase.

So what

Analyst Ravi Misra shifted his recommendation on the stock to buy from the previous hold. In doing so, he increased his price target by what's probably some kind of record lately -- to $252 per share from $157.

Misra is basing his changes on the ever-snowballing migration to remote medical services and the recently announced acquisition of Livongo Health (LVGO), another healthcare sector high flyer.

A Teladoc member using the company's interface.

Image source: Teladoc Health.

While both reasons are valid, it should be kept in mind that Teladoc (and Livongo, while we're at it) has been a stock on fire this year.

As effectively the remote doctor visit stock on the market, it's a no-brainer play on the stay-in-place restrictions engendered by the coronavirus pandemic. Even after a sell-off by skeptical investors following the announcement of the Livongo deal, Teladoc shares are still up by a whopping 166% year to date.

Now what

It feels as if the market is having second thoughts about Teladoc's lofty valuations, particularly considering the company has decided to swallow a big fish with the Livongo deal. Although an impressive company in certain ways, Teladoc's asset to be is similarly loss-making -- a challenge in and of itself -- and its business isn't necessarily a natural fit with that of its future owner.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Livongo Health Inc and Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health Stock Quote
Teladoc Health
TDOC
$27.60 (-3.40%) $0.97
Livongo Health Inc Stock Quote
Livongo Health Inc
LVGO

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
356%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.